Source: Market Watch
Pfizer Inc. PFE, +1.01% and BioNTech SE BNTX, +9.49% said the European Medicines Agency has decided to review data from their COVID-19 vaccine candidate on a rolling basis and has already started to evaluate data from pre-clinical trials. The decision “follows the encouraging preliminary results from pre-clinical and early clinical studies in adults, which suggest that BNT162b2 triggers the production of neutralizing antibodies and TH-1 dominant CD4+ and CD8+ T cells that target SARS-CoV-2,” the companies said in a joint statement. That combination of antibody and T Cell response is viewed as an important protection against viral infection and disease. A formal Marketing Authorization Application may follow if the vaccine proves efficacious and safe and submitted data are adequate, the statement said. The vaccine candidate is currently in a Phase 3 trial at more than 120 clinical sites around the world and has enrolled about 37,000 participants. “By reviewing the data as they become available, the CHMP can reach its opinion sooner on whether or not the investigational medicine or vaccine should be authorized,” the companies said. “After a positive opinion, if adopted by the CHMP, it is the European Commission’s role to grant a Marketing Authorization.” Pfizer shares were up 2% premarket, while BioNTech shares were up 10%.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE